Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03723226 · ClinicalTrials.gov registry record · NA

BFR and Muscle Mitochondrial Oxidative Capacity

A NA study of Hypertrophy and Strength, sponsored by Louisiana State University and A&M College.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03723226: Completed NA study of Hypertrophy and Strength, sponsored by Louisiana State University and A&M College.

NCT03723226 is a NA study of Hypertrophy and Strength that has completed, run by Louisiana State University and A&M College. The registered enrollment target is 24 participants, below the 32-participant average among 4 other Hypertrophy trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03723226, a NA study of Hypertrophy and Strength, has completed, sponsored by Louisiana State University and A&M College.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Blood flow restricted (BFR) exercise has been shown to improve skeletal muscle adaptations to resistance exercise. BFR uses blood pressure cuffs (i.e., tourniquets) to reduce skeletal muscle blood flow during resistance exercise. One benefit of BFR is that skeletal muscle adaptations to resistance exercise training including muscle hypertrophy and increases in strength can be achieved at lower-loads (e.g., 25-30% 1RM), that are often comparable to more traditional resistance training loads (70-85% 1RM). However, the impact that low-load BFR resistance exercise has on muscle quality and bioenergetics is unknown. The present study will examine the impact of 6 weeks of low-load, single-leg resistance exercise training with or without personalized BFR on measures of muscle mass, strength, quality, and mitochondrial bioenergetics. The investigators will recruit and study up to 30, previously sedentary, healthy, college-aged adults (18-40 years). The investigators will measure muscle mass using Dual Energy X-Ray Absorptiometry and muscle strength and endurance using isokinetic testing. The investigators will normalize knee extensor strength to lower limb lean mass to quantify muscle quality. The investigators will also use near infrared spectroscopy (NIRS) to measure mitochondrial oxidative capacity in the vastus lateralis. Finally, the investigators will measure markers of systemic inflammation and markers of muscle damage using commercially available ELISA assays.

Primary Outcome

Changes in mitochondrial oxidative capacity will be measured using near infrared spectroscopy (NIRS).

Interventions

  • BEHAVIORAL Low Load Resistance Exercise
  • BEHAVIORAL Low Load Resistance Exercise + BFR

Study Locations (1)

Louisiana

  • Lousiana State University - Baton Rouge

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-01-28
Est. Completion 2023-07-01
Phase NA

What the finished NCT03723226 record still lists

NCT03723226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 32-participant average among 4 other Hypertrophy trials with a reported enrollment target (25% lower).

The record links to 3 conditions, with Hypertrophy appearing as the primary indexed condition, and to 2 interventions - of which Low Load Resistance Exercise is the first listed.

NCT03723226 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT03723226 about?

NCT03723226 is a clinical study titled "BFR and Muscle Mitochondrial Oxidative Capacity". Blood flow restricted (BFR) exercise has been shown to improve skeletal muscle adaptations to resistance exercise. BFR uses blood pressure cuffs (i.e., tourniquets) to reduce skeletal muscle blood flow during resistance exercise. One benefit of BFR is that skeletal muscle adaptations to resistance e...

What is the current status of trial NCT03723226?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-01-28. Estimated completion is 2023-07-01.

What conditions does trial NCT03723226 study?

This clinical trial studies the following conditions: Hypertrophy, Strength, Mitochondria.

What interventions are being tested in trial NCT03723226?

The interventions under investigation include: Low Load Resistance Exercise (BEHAVIORAL), Low Load Resistance Exercise + BFR (BEHAVIORAL).

Who is sponsoring clinical trial NCT03723226?

This trial is sponsored by Louisiana State University and A&M College, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03723226 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03723226, the US trial registry maintained by the National Library of Medicine. NCT03723226 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.